If GLP-1R is not present in adipose tissue, one potential scenario for GLP-1 to execute its anti-obesity actions is that its responsive organs release anti-obesity endocrine signaling molecules that act on adipose tissue. The gene discussed is GCG; the disease is obesity disorder.